Prosecution Insights
Last updated: August 06, 2026

Kenvue Brands LLC

19 pending office actions • 14 art units • 19 examiners • 0 of 19 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Portfolio Summary

19
Total Pending OAs
5
Non-Final OAs
8
Final Rejections
6
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
1
Due this week
2
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (1)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (47%)
8
Medium (42%)
1
Easy (5%)
1
Unknown (5%)

Rejection Statute Mix

BucketCases
§101 + other1 (5%)
§103 only7 (37%)
§112 only1 (5%)
Double-patenting + other1 (5%)
Multi-statute (no §101)8 (42%)
No statute on record1 (5%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

13
Life Sciences
68% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
26% of docket
1
Business / Other
5% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WEBB III, JAMES L 1 14.5% +23.1%
HIRT, ERIN E 1 40.2% +22.2%
ALAOUIE, ALI MUSTAFA 1
WOOD, KIMBERLY T 1 54.4% +27.6%
ROZOF, TIMOTHY R 1 72.7% +23.9%
HENSON, DEVIN B 1 65.0% +43.6%
CARREIRO, CAITLIN ANN 1 45.6% +39.3%
TRUONG, QUANGLONG N 1 78.8% +23.5%
KASSA, TIGABU 1 36.6% +28.4%
MELLER, MICHAEL V 1 47.2% +28.1%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17948837 Method of Quantifying Product Impact on Human Microbiome GIAMMONA, FRANCESCA FILIPPA 175d overdue
18139476 TOPICAL COMPOSITIONS CONTAINING VITAMIN C SCOTLAND, REBECCA LYNN 45d overdue
18585836 PREMATURE AGING DETECTION USING DYNAMIC FACIAL IMAGING HENSON, DEVIN B 7d
18782894 MINERAL SUNSCREEN CONTAINING ZINC OXIDE AND TITANIUM DIOXIDE ALAOUIE, ALI MUSTAFA 13d
18910170 RISK ASSESSMENT SYSTEM WEBB III, JAMES L
18800473 CLEANSING COMPOSITIONS HIRT, ERIN E
18255388 MULTI-LAYERED PARTICLE COMPRISING SIMETHICONE TRAN, SUSAN T
18322135 ADVANCED METHOD AND KIT FOR WOUND TREATMENT BARHAM, BETHANY P

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18654220 METHODS SUITABLE FOR DISRUPTING A BIOFILM, AND/OR KILLING BACTERIA CONTAINED IN A BIOFILM ROZOF, TIMOTHY R 58d overdue
18585836 PREMATURE AGING DETECTION USING DYNAMIC FACIAL IMAGING HENSON, DEVIN B 7d
18475416 GUMMY DOSAGE FORMS TRUONG, QUANGLONG N 26d
18429879 EASILY REPLACEABLE ADHESIVE BANDAGE FOR ADVANCED WOUND HEALING AND METHOD CARREIRO, CAITLIN ANN 34d
18552211 COATED FAMOTIDINE PARTICLE KASSA, TIGABU 70d
18910170 RISK ASSESSMENT SYSTEM WEBB III, JAMES L
18800473 CLEANSING COMPOSITIONS HIRT, ERIN E
18733498 Systems, Methods, And Apparatus For Attaching An Otoscope Using An Angled Clip-On Device WOOD, KIMBERLY T

Top Art Units

Art UnitApps
1615 4
3791 2
3624 1
1614 1
3631 1
1625 1
3786 1
1619 1
1655 1
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18910170 RISK ASSESSMENT SYSTEM WEBB III, JAMES L 3624 §101§103 Final Rejection Pending Oct 09, 2024
18800473 CLEANSING COMPOSITIONS HIRT, ERIN E §103§112Other Non-Final OA Pending Aug 12, 2024
18782894 MINERAL SUNSCREEN CONTAINING ZINC OXIDE AND TITANIUM DIOXIDE ALAOUIE, ALI MUSTAFA 1614 §102§103Other Non-Final OA 13d Pending Jul 24, 2024
18733498 Systems, Methods, And Apparatus For Attaching An Otoscope Using An Angled Clip-On Device WOOD, KIMBERLY T 3631 §103 Final Rejection Pending Jun 04, 2024
18654220 METHODS SUITABLE FOR DISRUPTING A BIOFILM, AND/OR KILLING BACTERIA CONTAINED IN A BIOFILM ROZOF, TIMOTHY R 1625 Other Non-Final OA 58d overdue Pending May 03, 2024
18585836 PREMATURE AGING DETECTION USING DYNAMIC FACIAL IMAGING HENSON, DEVIN B 3791 §102§103§112 Non-Final OA 7d Pending Feb 23, 2024
18429879 EASILY REPLACEABLE ADHESIVE BANDAGE FOR ADVANCED WOUND HEALING AND METHOD CARREIRO, CAITLIN ANN 3786 §103Other Final Rejection 34d Pending Feb 01, 2024
18475416 GUMMY DOSAGE FORMS TRUONG, QUANGLONG N 1615 §103 Non-Final OA 26d Pending Sep 27, 2023
18552211 COATED FAMOTIDINE PARTICLE KASSA, TIGABU 1619 §103 Non-Final OA 70d Pending Sep 25, 2023
18551393 METHODS OF USING COMPOSITIONS COMPRISING AN ICELAND MOSS EXTRACT MELLER, MICHAEL V 1655 §103 Final Rejection Pending Sep 19, 2023
18550506 Umbilical Cord Sensors and Methods of Using the Same WINAKUR, ERIC FRANK 3791 §112 Final Rejection Pending Sep 14, 2023
18255388 MULTI-LAYERED PARTICLE COMPRISING SIMETHICONE TRAN, SUSAN T 1615 §103§112 Non-Final OA Pending Jun 01, 2023
18322135 ADVANCED METHOD AND KIT FOR WOUND TREATMENT BARHAM, BETHANY P 1611 §103§112 Non-Final OA Pending May 23, 2023
18139476 TOPICAL COMPOSITIONS CONTAINING VITAMIN C SCOTLAND, REBECCA LYNN 1615 §103§112 Final Rejection 45d overdue Pending Apr 26, 2023
18052707 Curable Absorbent Films DIGGS, TANISHA 1761 §103 Final Rejection 10d overdue Pending Nov 04, 2022
18052354 CUSTOMIZABLE DOSAGE FORMS CONTAINING SIMETHICONE YOUNG, MICAH PAUL 1618 §102§103 Non-Final OA Pending Nov 03, 2022
17948837 Method of Quantifying Product Impact on Human Microbiome GIAMMONA, FRANCESCA FILIPPA 1681 §103§112 Final Rejection 175d overdue Pending Sep 20, 2022
17522171 PRESERVATIVE CONTAINING COMPOSITIONS COPPINS, JANET L 1628 §103 Non-Final OA Pending Nov 09, 2021
17323392 MULTI-CAVITY CUSTOMIZABLE DOSAGE FORMS TCHERKASSKAYA, OLGA V 1615 §103§112DP Non-Final OA Pending May 18, 2021

Managing Kenvue Brands LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month